{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:13:38Z","timestamp":1789773218299,"version":"4.0.1"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,3]]},"DOI":"10.7759\/cureus.70780","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T16:51:30Z","timestamp":1727974290000},"source":"Crossref","is-referenced-by-count":3,"title":["Dupilumab Facial Redness (DFR) Cleared With Oral Itraconazole"],"prefix":"10.7759","author":[{"given":"Drashti","family":"Devani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Disha","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"De","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/ijd.ijd_860_20","article-title":"Real-world effectiveness and safety of dupilumab for the treatment of moderate to severe atopic dermatitis in Indian patients: a multi centric retrospective study","volume":"66","author":"Dhar S","year":"2021","unstructured":"Dhar S, De A, Srinivas SM. Real-world effectiveness and safety of dupilumab for the treatment of moderate to severe atopic dermatitis in Indian patients: a multi centric retrospective study. Indian J Dermatol. 2021, 66:297-301. 10.4103\/ijd.ijd_860_20","journal-title":"Indian J Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.06.1003","article-title":"Characterizing dupilumab facial redness in children and adolescents: a single-institution retrospective chart review","volume":"83","author":"Muzumdar S","year":"2020","unstructured":"Muzumdar S, Zubkov M, Waldman R, DeWane ME, Wu R, Grant-Kels JM. Characterizing dupilumab facial redness in children and adolescents: a single-institution retrospective chart review. J Am Acad Dermatol. 2020, 83:1520-1. 10.1016\/j.jaad.2020.06.1003","journal-title":"J Am Acad Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-021-00646-z","article-title":"Dupilumab facial redness\/dupilumab facial dermatitis: a guide for clinicians","volume":"23","author":"Muzumdar S","year":"2022","unstructured":"Muzumdar S, Skudalski L, Sharp K, Waldman RA. Dupilumab facial redness\/dupilumab facial dermatitis: a guide for clinicians. Am J Clin Dermatol. 2022, 23:61-7. 10.1007\/s40257-021-00646-z","journal-title":"Am J Clin Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0000000000000590","article-title":"A practical approach to recalcitrant face and neck dermatitis in atopic dermatitis","volume":"31","author":"Jaros J","year":"2020","unstructured":"Jaros J, Hendricks AJ, Shi VY, Lio PA. A practical approach to recalcitrant face and neck dermatitis in atopic dermatitis. Dermatitis. 2020, 31:169-77. 10.1097\/DER.0000000000000590","journal-title":"Dermatitis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.01.012","article-title":"Facial and neck erythema associated with dupilumab treatment: a systematic review","volume":"84","author":"Jo CE","year":"2021","unstructured":"Jo CE, Finstad A, Georgakopoulos JR, Piguet V, Yeung J, Drucker AM. Facial and neck erythema associated with dupilumab treatment: a systematic review. J Am Acad Dermatol. 2021, 84:1339-47. 10.1016\/j.jaad.2021.01.012","journal-title":"J Am Acad Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.06.026","article-title":"Characterizing dupilumab facial redness: a multi-institution retrospective medical record review","volume":"82","author":"Waldman RA","year":"2020","unstructured":"Waldman RA, DeWane ME, Sloan B, Grant-Kels JM. Characterizing dupilumab facial redness: a multi-institution retrospective medical record review. J Am Acad Dermatol. 2020, 82:230-2. 10.1016\/j.jaad.2019.06.026","journal-title":"J Am Acad Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.03.070","article-title":"Treatment of patients experiencing dupilumab facial redness with itraconazole and fluconazole: a single-institutional, retrospective medical record review","volume":"86","author":"Gao DX","year":"2022","unstructured":"Gao DX, Song S, Kahn JS, Cohen SR, Fiumara K, Dumont N, Rosmarin D. Treatment of patients experiencing dupilumab facial redness with itraconazole and fluconazole: a single-institutional, retrospective medical record review. J Am Acad Dermatol. 2022, 86:938-40. 10.1016\/j.jaad.2021.03.070","journal-title":"J Am Acad Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.1204a184","article-title":"Dupilumab-associated facial erythema successfully treated with oral ivermectin","volume":"12","author":"Liane JG","year":"2022","unstructured":"Liane JG, Morgado-Carrasco D. Dupilumab-associated facial erythema successfully treated with oral ivermectin. Dermatol Pract Concept. 2022, 12:e2022184. 10.5826\/dpc.1204a184","journal-title":"Dermatol Pract Concept"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/304248-dupilumab-facial-redness-dfr-cleared-with-oral-itraconazole","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T16:51:32Z","timestamp":1727974292000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/304248-dupilumab-facial-redness-dfr-cleared-with-oral-itraconazole"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,3]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.70780","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10,3]]}}}